Global Imipenem and Cilastatin Injection Market Research Report 2026

Imipenem and Cilastatin Injection Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Imipenem and Cilastatin Injection competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.

Imipenem and Cilastatin Injection is a carbapenem combination antibiotic supplied as a ready-to-use or reconstituted injectable solution. By combining imipenem with cilastatin at a fixed ratio, it preserves strong antibacterial activity against Gram-negative, Gram-positive, and anaerobic pathogens while reducing renal metabolism of the active component. It is widely used for severe pneumonia, sepsis, complicated intra-abdominal infections, complicated skin and soft tissue infections, and serious hospital-acquired infections associated with multidrug-resistant bacteria. The upstream supply chain mainly includes pharmaceutical-grade beta-lactam core structures and key side-chain intermediates, cilastatin raw material, solvents and stabilizing systems for injectable solutions, aseptic filling consumables and packaging materials, as well as GMP-compliant aseptic compounding, filling, and testing equipment, all of which require stringent control over process consistency, impurity profiles, and sterility assurance. Downstream customers primarily consist of general hospitals, tertiary hospitals, regional medical centers, and selected specialty hospitals, with utilization driven through centralized hospital procurement and reimbursement systems. Based on ex-factory pricing, global nominal production capacity of imipenem and cilastatin injection in 2025 is estimated at approximately 56.0 million units, with actual sales volume of around 43.65 million units and an average global ex-factory price of about USD 10.4 per unit. Constrained by technical barriers in sterile injectable manufacturing, intensive quality system requirements, and sustained pricing pressure from hospital tenders, leading manufacturers typically achieve gross margins in the range of 42%–58%, reflecting a mature market characterized by stable demand, competitive dynamics, and scale- and compliance-driven profitability.

The North American market for Imipenem and Cilastatin Injection is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Imipenem and Cilastatin Injection is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

Major global manufacturers of Imipenem and Cilastatin Injection include Merck, Fresenius, Venus Remedies, Sun Pharmaceutical, JW Pharmaceutical, Taiwan Biotech, Zhuhai United Laboratories, Hanhui Pharmaceuticals, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Imipenem and Cilastatin Injection market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Imipenem and Cilastatin Injection. The Imipenem and Cilastatin Injection market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Imipenem and Cilastatin Injection market comprehensively. Regional market sizes by Type, by Application, by Clinical Indication, and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Imipenem and Cilastatin Injection manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Imipenem and Cilastatin Injection Market Report

Chapter Outline

1.1 Product Definition

1.2 Imipenem and Cilastatin Injection by Type

1.2.1 Global Imipenem and Cilastatin Injection Market Value by Type: 2025 vs 2032

1.2.2 0.5g

1.2.3 1.0g

1.2.4 2.0g

1.3 Imipenem and Cilastatin Injection by Clinical Indication

1.3.1 Global Imipenem and Cilastatin Injection Market Value by Clinical Indication: 2025 vs 2032

1.3.2 Severe Hospital-acquired Infections

1.3.3 Multidrug-resistant Bacterial Infections

1.3.4 Others

1.4 Imipenem and Cilastatin Injection by Application

1.4.1 Global Imipenem and Cilastatin Injection Market Value by Application: 2025 vs 2032

1.4.2 Hospital

1.4.3 Clinic

1.4.4 Others

1.5 Global Imipenem and Cilastatin Injection Market Size Estimates and Forecasts

1.5.1 Global Imipenem and Cilastatin Injection Revenue 2021–2032

1.5.2 Global Imipenem and Cilastatin Injection Sales 2021–2032

1.5.3 Global Imipenem and Cilastatin Injection Market Average Price (2021–2032)

1.6 Assumptions and Limitations

2.1 Global Imipenem and Cilastatin Injection Sales Market Share by Manufacturers (2021–2026)

2.2 Global Imipenem and Cilastatin Injection Revenue Market Share by Manufacturers (2021–2026)

2.3 Global Imipenem and Cilastatin Injection Average Price by Manufacturers (2021–2026)

2.4 Global Key Players of Imipenem and Cilastatin Injection, Industry Ranking, 2023 vs 2024 vs 2025

2.5 Global Key Manufacturers of Imipenem and Cilastatin Injection, Manufacturing Sites and Headquarters

2.6 Global Key Manufacturers of Imipenem and Cilastatin Injection, Product Types and Applications

2.7 Global Key Manufacturers of Imipenem and Cilastatin Injection, Date of Entry into the Industry

2.8 Global Imipenem and Cilastatin Injection Market Competitive Situation and Trends

2.8.1 Global Imipenem and Cilastatin Injection Market Concentration Rate

2.8.2 The Top 5 and Top 10 Global Imipenem and Cilastatin Injection Players Market Share by Revenue

2.8.3 Global Imipenem and Cilastatin Injection Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Imipenem and Cilastatin Injection Market Size by Region: 2021 vs 2025 vs 2032

3.2 Global Imipenem and Cilastatin Injection Sales by Region: 2021–2032

3.2.1 Global Imipenem and Cilastatin Injection Sales by Region: 2021–2026

3.2.2 Global Imipenem and Cilastatin Injection Sales by Region: 2027–2032

3.3 Global Imipenem and Cilastatin Injection Revenue by Region: 2021–2032

3.3.1 Global Imipenem and Cilastatin Injection Revenue by Region: 2021–2026

3.3.2 Global Imipenem and Cilastatin Injection Revenue by Region: 2027–2032

3.4 North America Imipenem and Cilastatin Injection Market Facts & Figures by Country

3.4.1 North America Imipenem and Cilastatin Injection Market Size by Country: 2021 vs 2025 vs 2032

3.4.2 North America Imipenem and Cilastatin Injection Sales by Country (2021–2032)

3.4.3 North America Imipenem and Cilastatin Injection Revenue by Country (2021–2032)

3.4.4 United States

3.4.5 Canada

3.5 Europe Imipenem and Cilastatin Injection Market Facts & Figures by Country

3.5.1 Europe Imipenem and Cilastatin Injection Market Size by Country: 2021 vs 2025 vs 2032

3.5.2 Europe Imipenem and Cilastatin Injection Sales by Country (2021–2032)

3.5.3 Europe Imipenem and Cilastatin Injection Revenue by Country (2021–2032)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Imipenem and Cilastatin Injection Market Facts & Figures by Region

3.6.1 Asia Pacific Imipenem and Cilastatin Injection Market Size by Region: 2021 vs 2025 vs 2032

3.6.2 Asia Pacific Imipenem and Cilastatin Injection Sales by Region (2021–2032)

3.6.3 Asia Pacific Imipenem and Cilastatin Injection Revenue by Region (2021–2032)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Imipenem and Cilastatin Injection Market Facts & Figures by Country

3.7.1 Latin America Imipenem and Cilastatin Injection Market Size by Country: 2021 vs 2025 vs 2032

3.7.2 Latin America Imipenem and Cilastatin Injection Sales by Country (2021–2032)

3.7.3 Latin America Imipenem and Cilastatin Injection Revenue by Country (2021–2032)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Imipenem and Cilastatin Injection Market Facts & Figures by Country

3.8.1 Middle East and Africa Imipenem and Cilastatin Injection Market Size by Country: 2021 vs 2025 vs 2032

3.8.2 Middle East and Africa Imipenem and Cilastatin Injection Sales by Country (2021–2032)

3.8.3 Middle East and Africa Imipenem and Cilastatin Injection Revenue by Country (2021–2032)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Imipenem and Cilastatin Injection Sales by Type (2021–2032)

4.1.1 Global Imipenem and Cilastatin Injection Sales by Type (2021–2026)

4.1.2 Global Imipenem and Cilastatin Injection Sales by Type (2027–2032)

4.1.3 Global Imipenem and Cilastatin Injection Sales Market Share by Type (2021–2032)

4.2 Global Imipenem and Cilastatin Injection Revenue by Type (2021–2032)

4.2.1 Global Imipenem and Cilastatin Injection Revenue by Type (2021–2026)

4.2.2 Global Imipenem and Cilastatin Injection Revenue by Type (2027–2032)

4.2.3 Global Imipenem and Cilastatin Injection Revenue Market Share by Type (2021–2032)

4.3 Global Imipenem and Cilastatin Injection Price by Type (2021–2032)

5.1 Global Imipenem and Cilastatin Injection Sales by Application (2021–2032)

5.1.1 Global Imipenem and Cilastatin Injection Sales by Application (2021–2026)

5.1.2 Global Imipenem and Cilastatin Injection Sales by Application (2027–2032)

5.1.3 Global Imipenem and Cilastatin Injection Sales Market Share by Application (2021–2032)

5.2 Global Imipenem and Cilastatin Injection Revenue by Application (2021–2032)

5.2.1 Global Imipenem and Cilastatin Injection Revenue by Application (2021–2026)

5.2.2 Global Imipenem and Cilastatin Injection Revenue by Application (2027–2032)

5.2.3 Global Imipenem and Cilastatin Injection Revenue Market Share by Application (2021–2032)

5.3 Global Imipenem and Cilastatin Injection Price by Application (2021–2032)

6.1 Merck

6.1.1 Merck Company Information

6.1.2 Merck Description and Business Overview

6.1.3 Merck Imipenem and Cilastatin Injection Sales, Revenue, and Gross Margin (2021–2026)

6.1.4 Merck Imipenem and Cilastatin Injection Product Portfolio

6.1.5 Merck Recent Developments/Updates

6.2 Fresenius

6.2.1 Fresenius Company Information

6.2.2 Fresenius Description and Business Overview

6.2.3 Fresenius Imipenem and Cilastatin Injection Sales, Revenue, and Gross Margin (2021–2026)

6.2.4 Fresenius Imipenem and Cilastatin Injection Product Portfolio

6.2.5 Fresenius Recent Developments/Updates

6.3 Venus Remedies

6.3.1 Venus Remedies Company Information

6.3.2 Venus Remedies Description and Business Overview

6.3.3 Venus Remedies Imipenem and Cilastatin Injection Sales, Revenue, and Gross Margin (2021–2026)

6.3.4 Venus Remedies Imipenem and Cilastatin Injection Product Portfolio

6.3.5 Venus Remedies Recent Developments/Updates

6.4 Sun Pharmaceutical

6.4.1 Sun Pharmaceutical Company Information

6.4.2 Sun Pharmaceutical Description and Business Overview

6.4.3 Sun Pharmaceutical Imipenem and Cilastatin Injection Sales, Revenue, and Gross Margin (2021–2026)

6.4.4 Sun Pharmaceutical Imipenem and Cilastatin Injection Product Portfolio

6.4.5 Sun Pharmaceutical Recent Developments/Updates

6.5 JW Pharmaceutical

6.5.1 JW Pharmaceutical Company Information

6.5.2 JW Pharmaceutical Description and Business Overview

6.5.3 JW Pharmaceutical Imipenem and Cilastatin Injection Sales, Revenue, and Gross Margin (2021–2026)

6.5.4 JW Pharmaceutical Imipenem and Cilastatin Injection Product Portfolio

6.5.5 JW Pharmaceutical Recent Developments/Updates

6.6 Taiwan Biotech

6.6.1 Taiwan Biotech Company Information

6.6.2 Taiwan Biotech Description and Business Overview

6.6.3 Taiwan Biotech Imipenem and Cilastatin Injection Sales, Revenue, and Gross Margin (2021–2026)

6.6.4 Taiwan Biotech Imipenem and Cilastatin Injection Product Portfolio

6.6.5 Taiwan Biotech Recent Developments/Updates

6.7 Zhuhai United Laboratories

6.7.1 Zhuhai United Laboratories Company Information

6.7.2 Zhuhai United Laboratories Description and Business Overview

6.7.3 Zhuhai United Laboratories Imipenem and Cilastatin Injection Sales, Revenue, and Gross Margin (2021–2026)

6.7.4 Zhuhai United Laboratories Imipenem and Cilastatin Injection Product Portfolio

6.7.5 Zhuhai United Laboratories Recent Developments/Updates

6.8 Hanhui Pharmaceuticals

6.8.1 Hanhui Pharmaceuticals Company Information

6.8.2 Hanhui Pharmaceuticals Description and Business Overview

6.8.3 Hanhui Pharmaceuticals Imipenem and Cilastatin Injection Sales, Revenue, and Gross Margin (2021–2026)

6.8.4 Hanhui Pharmaceuticals Imipenem and Cilastatin Injection Product Portfolio

6.8.5 Hanhui Pharmaceuticals Recent Developments/Updates

7.1 Imipenem and Cilastatin Injection Industry Chain Analysis

7.2 Imipenem and Cilastatin Injection Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Imipenem and Cilastatin Injection Production Mode & Process Analysis

7.4 Imipenem and Cilastatin Injection Sales and Marketing

7.4.1 Imipenem and Cilastatin Injection Sales Channels

7.4.2 Imipenem and Cilastatin Injection Distributors

7.5 Imipenem and Cilastatin Injection Customer Analysis

8.1 Imipenem and Cilastatin Injection Industry Trends

8.2 Imipenem and Cilastatin Injection Market Drivers

8.3 Imipenem and Cilastatin Injection Market Challenges

8.4 Imipenem and Cilastatin Injection Market Restraints

8.5 Impact of U.S. Tariffs

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

 Table 1. Global Imipenem and Cilastatin Injection Market Value by Type (US$ Million), 2025 vs 2032

 Table 2. Global Imipenem and Cilastatin Injection Market Value by Clinical Indication (US$ Million), 2025 vs 2032

 Table 3. Global Imipenem and Cilastatin Injection Market Value by Application (US$ Million), 2025 vs 2032

 Table 4. Global Imipenem and Cilastatin Injection Market Competitive Situation by Manufacturers in 2025

 Table 5. Global Imipenem and Cilastatin Injection Sales (K Units) of Key Manufacturers (2021–2026)

 Table 6. Global Imipenem and Cilastatin Injection Sales Market Share by Manufacturers (2021–2026)

 Table 7. Global Imipenem and Cilastatin Injection Revenue (US$ Million) by Manufacturers (2021–2026)

 Table 8. Global Imipenem and Cilastatin Injection Revenue Share by Manufacturers (2021–2026)

 Table 9. Global Market Imipenem and Cilastatin Injection Average Price (US$/Unit) of Key Manufacturers (2021–2026)

 Table 10. Global Key Players of Imipenem and Cilastatin Injection, Industry Ranking, 2023 vs 2024 vs 2025

 Table 11. Global Key Manufacturers of Imipenem and Cilastatin Injection, Manufacturing Sites and Headquarters

 Table 12. Global Key Manufacturers of Imipenem and Cilastatin Injection, Product Types and Applications

 Table 13. Global Key Manufacturers of Imipenem and Cilastatin Injection, Date of Entry into the Industry

 Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

 Table 15. Global Imipenem and Cilastatin Injection Companies by Tier (Tier 1, Tier 2, Tier 3), based on Imipenem and Cilastatin Injection Revenue, 2025

 Table 16. Manufacturers Mergers & Acquisitions, Expansion Plans

 Table 17. Global Imipenem and Cilastatin Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

 Table 18. Global Imipenem and Cilastatin Injection Sales by Region (K Units), 2021–2026

 Table 19. Global Imipenem and Cilastatin Injection Sales Market Share by Region (2021–2026)

 Table 20. Global Imipenem and Cilastatin Injection Sales by Region (K Units), 2027–2032

 Table 21. Global Imipenem and Cilastatin Injection Sales Market Share by Region (2027–2032)

 Table 22. Global Imipenem and Cilastatin Injection Revenue by Region (US$ Million), 2021–2026

 Table 23. Global Imipenem and Cilastatin Injection Revenue Market Share by Region (2021–2026)

 Table 24. Global Imipenem and Cilastatin Injection Revenue by Region (US$ Million), 2027–2032

 Table 25. Global Imipenem and Cilastatin Injection Revenue Market Share by Region (2027–2032)

 Table 26. North America Imipenem and Cilastatin Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 27. North America Imipenem and Cilastatin Injection Sales by Country (K Units), 2021–2026

 Table 28. North America Imipenem and Cilastatin Injection Sales by Country (K Units), 2027–2032

 Table 29. North America Imipenem and Cilastatin Injection Revenue by Country (US$ Million), 2021–2026

 Table 30. North America Imipenem and Cilastatin Injection Revenue by Country (US$ Million), 2027–2032

 Table 31. Europe Imipenem and Cilastatin Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 32. Europe Imipenem and Cilastatin Injection Sales by Country (K Units), 2021–2026

 Table 33. Europe Imipenem and Cilastatin Injection Sales by Country (K Units), 2027–2032

 Table 34. Europe Imipenem and Cilastatin Injection Revenue by Country (US$ Million), 2021–2026

 Table 35. Europe Imipenem and Cilastatin Injection Revenue by Country (US$ Million), 2027–2032

 Table 36. Asia Pacific Imipenem and Cilastatin Injection Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)

 Table 37. Asia Pacific Imipenem and Cilastatin Injection Sales by Region (K Units), 2021–2026

 Table 38. Asia Pacific Imipenem and Cilastatin Injection Sales by Region (K Units), 2027–2032

 Table 39. Asia Pacific Imipenem and Cilastatin Injection Revenue by Region (US$ Million), 2021–2026

 Table 40. Asia Pacific Imipenem and Cilastatin Injection Revenue by Region (US$ Million), 2027–2032

 Table 41. Latin America Imipenem and Cilastatin Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 42. Latin America Imipenem and Cilastatin Injection Sales by Country (K Units), 2021–2026

 Table 43. Latin America Imipenem and Cilastatin Injection Sales by Country (K Units), 2027–2032

 Table 44. Latin America Imipenem and Cilastatin Injection Revenue by Country (US$ Million), 2021–2026

 Table 45. Latin America Imipenem and Cilastatin Injection Revenue by Country (US$ Million), 2027–2032

 Table 46. Middle East and Africa Imipenem and Cilastatin Injection Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)

 Table 47. Middle East and Africa Imipenem and Cilastatin Injection Sales by Country (K Units), 2021–2026

 Table 48. Middle East and Africa Imipenem and Cilastatin Injection Sales by Country (K Units), 2027–2032

 Table 49. Middle East and Africa Imipenem and Cilastatin Injection Revenue by Country (US$ Million), 2021–2026

 Table 50. Middle East and Africa Imipenem and Cilastatin Injection Revenue by Country (US$ Million), 2027–2032

 Table 51. Global Imipenem and Cilastatin Injection Sales (K Units) by Type (2021–2026)

 Table 52. Global Imipenem and Cilastatin Injection Sales (K Units) by Type (2027–2032)

 Table 53. Global Imipenem and Cilastatin Injection Sales Market Share by Type (2021–2026)

 Table 54. Global Imipenem and Cilastatin Injection Sales Market Share by Type (2027–2032)

 Table 55. Global Imipenem and Cilastatin Injection Revenue (US$ Million) by Type (2021–2026)

 Table 56. Global Imipenem and Cilastatin Injection Revenue (US$ Million) by Type (2027–2032)

 Table 57. Global Imipenem and Cilastatin Injection Revenue Market Share by Type (2021–2026)

 Table 58. Global Imipenem and Cilastatin Injection Revenue Market Share by Type (2027–2032)

 Table 59. Global Imipenem and Cilastatin Injection Price (US$/Unit) by Type (2021–2026)

 Table 60. Global Imipenem and Cilastatin Injection Price (US$/Unit) by Type (2027–2032)

 Table 61. Global Imipenem and Cilastatin Injection Sales (K Units) by Application (2021–2026)

 Table 62. Global Imipenem and Cilastatin Injection Sales (K Units) by Application (2027–2032)

 Table 63. Global Imipenem and Cilastatin Injection Sales Market Share by Application (2021–2026)

 Table 64. Global Imipenem and Cilastatin Injection Sales Market Share by Application (2027–2032)

 Table 65. Global Imipenem and Cilastatin Injection Revenue (US$ Million) by Application (2021–2026)

 Table 66. Global Imipenem and Cilastatin Injection Revenue (US$ Million) by Application (2027–2032)

 Table 67. Global Imipenem and Cilastatin Injection Revenue Market Share by Application (2021–2026)

 Table 68. Global Imipenem and Cilastatin Injection Revenue Market Share by Application (2027–2032)

 Table 69. Global Imipenem and Cilastatin Injection Price (US$/Unit) by Application (2021–2026)

 Table 70. Global Imipenem and Cilastatin Injection Price (US$/Unit) by Application (2027–2032)

 Table 71. Merck Company Information

 Table 72. Merck Description and Business Overview

 Table 73. Merck Imipenem and Cilastatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 74. Merck Imipenem and Cilastatin Injection Product

 Table 75. Merck Recent Developments/Updates

 Table 76. Fresenius Company Information

 Table 77. Fresenius Description and Business Overview

 Table 78. Fresenius Imipenem and Cilastatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 79. Fresenius Imipenem and Cilastatin Injection Product

 Table 80. Fresenius Recent Developments/Updates

 Table 81. Venus Remedies Company Information

 Table 82. Venus Remedies Description and Business Overview

 Table 83. Venus Remedies Imipenem and Cilastatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 84. Venus Remedies Imipenem and Cilastatin Injection Product

 Table 85. Venus Remedies Recent Developments/Updates

 Table 86. Sun Pharmaceutical Company Information

 Table 87. Sun Pharmaceutical Description and Business Overview

 Table 88. Sun Pharmaceutical Imipenem and Cilastatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 89. Sun Pharmaceutical Imipenem and Cilastatin Injection Product

 Table 90. Sun Pharmaceutical Recent Developments/Updates

 Table 91. JW Pharmaceutical Company Information

 Table 92. JW Pharmaceutical Description and Business Overview

 Table 93. JW Pharmaceutical Imipenem and Cilastatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 94. JW Pharmaceutical Imipenem and Cilastatin Injection Product

 Table 95. JW Pharmaceutical Recent Developments/Updates

 Table 96. Taiwan Biotech Company Information

 Table 97. Taiwan Biotech Description and Business Overview

 Table 98. Taiwan Biotech Imipenem and Cilastatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 99. Taiwan Biotech Imipenem and Cilastatin Injection Product

 Table 100. Taiwan Biotech Recent Developments/Updates

 Table 101. Zhuhai United Laboratories Company Information

 Table 102. Zhuhai United Laboratories Description and Business Overview

 Table 103. Zhuhai United Laboratories Imipenem and Cilastatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 104. Zhuhai United Laboratories Imipenem and Cilastatin Injection Product

 Table 105. Zhuhai United Laboratories Recent Developments/Updates

 Table 106. Hanhui Pharmaceuticals Company Information

 Table 107. Hanhui Pharmaceuticals Description and Business Overview

 Table 108. Hanhui Pharmaceuticals Imipenem and Cilastatin Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)

 Table 109. Hanhui Pharmaceuticals Imipenem and Cilastatin Injection Product

 Table 110. Hanhui Pharmaceuticals Recent Developments/Updates

 Table 111. Key Raw Materials Lists

 Table 112. Raw Materials Key Suppliers Lists

 Table 113. Imipenem and Cilastatin Injection Distributors List

 Table 114. Imipenem and Cilastatin Injection Customers List

 Table 115. Imipenem and Cilastatin Injection Market Trends

 Table 116. Imipenem and Cilastatin Injection Market Drivers

 Table 117. Imipenem and Cilastatin Injection Market Challenges

 Table 118. Imipenem and Cilastatin Injection Market Restraints

 Table 119. Research Programs/Design for This Report

 Table 120. Key Data Information from Secondary Sources

 Table 121. Key Data Information from Primary Sources

 Table 122. Authors List of This Report

List of Figures

 Figure 1. Product Picture of Imipenem and Cilastatin Injection

 Figure 2. Global Imipenem and Cilastatin Injection Market Value by Type (US$ Million), 2021–2032

 Figure 3. Global Imipenem and Cilastatin Injection Market Share by Type: 2025 & 2032

 Figure 4. 0.5g Product Picture

 Figure 5. 1.0g Product Picture

 Figure 6. 2.0g Product Picture

 Figure 7. Global Imipenem and Cilastatin Injection Market Value by Clinical Indication (US$ Million), 2021–2032

 Figure 8. Global Imipenem and Cilastatin Injection Market Share by Clinical Indication: 2025 vs 2032

 Figure 9. Severe Hospital-acquired Infections Product Picture

 Figure 10. Multidrug-resistant Bacterial Infections Product Picture

 Figure 11. Others Product Picture

 Figure 12. Global Imipenem and Cilastatin Injection Market Value by Application (US$ Million), 2021–2032

 Figure 13. Global Imipenem and Cilastatin Injection Market Share by Application: 2025 & 2032

 Figure 14. Hospital

 Figure 15. Clinic

 Figure 16. Others

 Figure 17. Global Imipenem and Cilastatin Injection Revenue, (US$ Million), 2021 vs 2025 vs 2032

 Figure 18. Global Imipenem and Cilastatin Injection Market Size (US$ Million), 2021–2032

 Figure 19. Global Imipenem and Cilastatin Injection Sales (K Units), 2021–2032

 Figure 20. Global Imipenem and Cilastatin Injection Average Price (US$/Unit), 2021–2032

 Figure 21. Imipenem and Cilastatin Injection Report Years Considered

 Figure 22. Imipenem and Cilastatin Injection Sales Share by Manufacturers in 2025

 Figure 23. Global Imipenem and Cilastatin Injection Revenue Share by Manufacturers in 2025

 Figure 24. Top 5 and Top 10 Global Imipenem and Cilastatin Injection Players: Market Share by Revenue in Imipenem and Cilastatin Injection in 2025

 Figure 25. Imipenem and Cilastatin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025

 Figure 26. Global Imipenem and Cilastatin Injection Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

 Figure 27. North America Imipenem and Cilastatin Injection Sales Market Share by Country (2021–2032)

 Figure 28. North America Imipenem and Cilastatin Injection Revenue Market Share by Country (2021–2032)

 Figure 29. United States Imipenem and Cilastatin Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 30. Canada Imipenem and Cilastatin Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 31. Europe Imipenem and Cilastatin Injection Sales Market Share by Country (2021–2032)

 Figure 32. Europe Imipenem and Cilastatin Injection Revenue Market Share by Country (2021–2032)

 Figure 33. Germany Imipenem and Cilastatin Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 34. France Imipenem and Cilastatin Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 35. U.K. Imipenem and Cilastatin Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 36. Italy Imipenem and Cilastatin Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 37. Russia Imipenem and Cilastatin Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 38. Asia Pacific Imipenem and Cilastatin Injection Sales Market Share by Region (2021–2032)

 Figure 39. Asia Pacific Imipenem and Cilastatin Injection Revenue Market Share by Region (2021–2032)

 Figure 40. China Imipenem and Cilastatin Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 41. Japan Imipenem and Cilastatin Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 42. South Korea Imipenem and Cilastatin Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 43. India Imipenem and Cilastatin Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 44. Australia Imipenem and Cilastatin Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 45. China Taiwan Imipenem and Cilastatin Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 46. Southeast Asia Imipenem and Cilastatin Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 47. Latin America Imipenem and Cilastatin Injection Sales Market Share by Country (2021–2032)

 Figure 48. Latin America Imipenem and Cilastatin Injection Revenue Market Share by Country (2021–2032)

 Figure 49. Mexico Imipenem and Cilastatin Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 50. Brazil Imipenem and Cilastatin Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 51. Argentina Imipenem and Cilastatin Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 52. Colombia Imipenem and Cilastatin Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 53. Middle East and Africa Imipenem and Cilastatin Injection Sales Market Share by Country (2021–2032)

 Figure 54. Middle East and Africa Imipenem and Cilastatin Injection Revenue Market Share by Country (2021–2032)

 Figure 55. Turkey Imipenem and Cilastatin Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 56. Saudi Arabia Imipenem and Cilastatin Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 57. UAE Imipenem and Cilastatin Injection Revenue Growth Rate (US$ Million), 2021–2032

 Figure 58. Global Sales Market Share of Imipenem and Cilastatin Injection by Type (2021–2032)

 Figure 59. Global Revenue Market Share of Imipenem and Cilastatin Injection by Type (2021–2032)

 Figure 60. Global Imipenem and Cilastatin Injection Price (US$/Unit) by Type (2021–2032)

 Figure 61. Global Sales Market Share of Imipenem and Cilastatin Injection by Application (2021–2032)

 Figure 62. Global Revenue Market Share of Imipenem and Cilastatin Injection by Application (2021–2032)

 Figure 63. Global Imipenem and Cilastatin Injection Price (US$/Unit) by Application (2021–2032)

 Figure 64. Imipenem and Cilastatin Injection Value Chain

 Figure 65. Channels of Distribution (Direct Vs Distribution)

 Figure 66. Bottom-up and Top-down Approaches for This Report

 Figure 67. Data Triangulation

 Figure 68. Key Executives Interviewed